Furthermore, a recent article indicated a shorter overall survival between patients with rectal cancer and high IMP3 protein levels respect to the same patients without or with low levels of IMP3 expression [20], proposing IMP3 evaluation by immunohistochemistry as an independent prognostic factor of the clinical stage of rectal cancer [20]. This evidence concerns the gene IMP3 and rectal cancer.